⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14922420 | 0.83 | — | — | |
| SCHEMBL25038788 | 0.82 | — | — | |
| SCHEMBL14240725 | 0.82 | — | — | |
| SCHEMBL13786730 | 0.81 | ALDH1A1 (0.33) | — | |
| SCHEMBL8344137 | 0.79 | — | — | |
| SCHEMBL14865200 | 0.79 | ALDH1A1 (0.32) | — | |
| SCHEMBL18413403 | 0.79 | — | — | |
| SCHEMBL7058950 | 0.78 | TSHR (0.45) | — | |
| SCHEMBL18389724 | 0.78 | LMNA (0.30) | — | |
| SCHEMBL12214390 | 0.78 | GRIK1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11637256-B2 | Quantum dots with charge-transporting ligands | NANOSYS, INC. (US) | 2023-04-25 | — | — | US | disclosed |
| US-10875834-B2 | Prodrug and protected forms of 5-hydroxymethylfurfuranal (5-HMF) and its derivatives | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2020-12-29 | — | — | US | disclosed |
| US-10804467-B2 | Method of manufacturing organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-10-13 | — | — | US | disclosed |
| US-20200067006-A1 | QUANTUM DOTS WITH CHARGE-TRANSPORTING LIGANDS | NANOSYS, INC. (US) | 2020-02-27 | — | — | US | disclosed |
| WO-2020040982-A1 | QUANTUM DOTS WITH CHARGE-TRANSPORTING LIGANDS | NANOSYS, INC. (US) | 2020-02-27 | — | — | WO | disclosed |
| US-20190256483-A1 | PRODRUG AND PROTECTED FORMS OF 5-HYDROXYMETHYLFURFURANAL (5-HMF) AND ITS DERIVATIVES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2019-08-22 | — | — | US | disclosed |
| US-20180130949-A1 | METHOD OF MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-10 | — | — | US | disclosed |
| WO-2017201532-A1 | METHODS AND COMPOSITIONS FOR TREATING NON-ERK MAPK PATHWAY INHIBITOR-RESISTANT CANCERS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2017-11-23 | — | — | WO | disclosed |
| US-20160317517-A1 | CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORS | BIOMED VALLEY DISCOVERIES, INC. | 2016-11-03 | — | — | US | disclosed |
| WO-2016123581-A1 | CRYSTALLINE C21H22C12N4O2 MALONATE | BIOMED VALLEY DISCOVERIES, INC. (US) | 2016-08-04 | — | — | WO | disclosed |
| WO-2015095842-A2 | METHODS AND COMPOSITIONS FOR TREATING NON-ERK MAPK PATHWAY INHIBITOR-RESISTANT CANCERS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2015-06-25 | — | — | WO | disclosed |
| WO-2014160967-A9 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2014-12-24 | — | — | WO | disclosed |
| WO-2014160950-A1 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| WO-2014160967-A2 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS | BIOMED VALLEY DISCOVERIES, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| US-8709299-B2 | Dye sensitised solar cell | BASF SE (DE) | 2014-04-29 | — | — | US | disclosed |
| US-20130112106-A1 | ENVIRONMENTALLY FRIENDLY CORROSION INHIBITOR | APERGY ESP SYSTEMS, LLC | 2013-05-09 | — | — | US | disclosed |
| WO-2012170371-A1 | COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS | N30 PHARMACEUTICALS, LLC (US) | 2012-12-13 | — | — | WO | disclosed |
| WO-2012089127-A1 | CERTAIN DIPEPTIDYL PEPTIDASE INHIBITORS | SHANGHAI FOCHON PHARMACEUTICAL CO LTD (CN) | 2012-07-05 | — | — | WO | disclosed |
| US-7531669-B2 | Methods for treating neural disorders and conditions, and compounds useful therefor | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2009-05-12 | — | — | US | disclosed |
| WO-2008043846-A2 | NEW ISOCARBOSTYRIL ALKALOID DERIVATIVES HAVING ANTI-PROLIFERATIVE AND ANTI-MIGRATORY ACTIVITIES | UNIBIOSCREEN SA (BE) | 2008-04-17 | — | — | WO | disclosed |